Isagenix Study Published in Peer-Reviewed Journals
The studies were conducted by researchers at Skidmore College in New York under the direction of principal investigator Paul J. Arciero, Ph.D., and designed to see if Isagenix products aided in effective weight loss and long-term weight maintenance. The study was broken into two phases: Phase One lasting 12 weeks and Phase Two lasting 52 weeks.
Results showed study participants on average lost a total of one third their visceral fat (located around one’s midsection), gained lean mass, had better arterial health, and enhanced metabolism after using Isagenix products.
“As an active nutrition and exercise science researcher for over 30 years, these were very impressive findings and clearly established our protein-pacing [Shake Days] and intermittent fasting diet regimen [Cleanse Days] as an effective short- and long-term strategy to promote healthy body weight, abdominal and visceral fat mass loss as well as enhanced metabolism and cardiovascular health compared to other commonly prescribed diets,” Dr. Arciero said.
The success of this study was in conjunction with the Isagenix 30-Day System. For the last 14 years, Isagenix has been developing cutting-edge products that help target five key areas: weight loss, healthy aging, energy, performance, and wealth creation. To date, the health and wellness company has helped thousands find a solution for shredding unwanted pounds, boosting energy, improving endurance, and creating residual income.
This is the fourth time Isagenix had a study published in a peer-review journal and shows the company’s continued commitment to scientific research on its products.
The new Skidmore College study was registered at National Institute of Health’s ClinicalTrials.gov, a publicly and privately supported registry of clinical studies conducted around the world.
About Isagenix International
Established in 2002, Isagenix provides systems for weight loss, energy, performance, healthy aging, and wealth creation. With nearly 600,000 customers worldwide and more than 100 life-changing products, packs, and systems globally, the company is committed to producing Solutions to Transform Lives™. Since its inception in 2002, Isagenix has generated $6 billion in cumulative global sales through a network of independent distributors in the U.S., Canada, Puerto Rico, Hong Kong, Australia, New Zealand, Taiwan, Mexico, Singapore, Malaysia, Colombia, Indonesia, the United Kingdom, Ireland, the Netherlands, Belgium, Spain, and South Korea. Isagenix is a privately owned company with headquarters in Gilbert, Arizona. For more information, visit Isagenix.com.